A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 10: 673-686, 2023.
Article
en En
| MEDLINE
| ID: mdl-37125392
Texto completo:
1
Bases de datos:
MEDLINE
Idioma:
En
Revista:
J Hepatocell Carcinoma
Año:
2023
Tipo del documento:
Article